Edition:
United Kingdom

Recipharm AB (publ) (RECIb.ST)

RECIb.ST on Stockholm Stock Exchange

103.80SEK
23 Jan 2018
Change (% chg)

-0.20kr (-0.19%)
Prev Close
104.00kr
Open
104.40kr
Day's High
105.20kr
Day's Low
102.80kr
Volume
39,148
Avg. Vol
122,441
52-wk High
131.00kr
52-wk Low
84.00kr

Select another date:

Tue, Jan 2 2018

BRIEF-Recipharm Buys Remaining Shares In Nitin Lifesciences

* RECIPHARM ACQUIRES REMAINING SHARES IN NITIN LIFESCIENCES LTD

BRIEF-Recipharm commences new supply contract

* RECIPHARM COMMENCES NEW SUPPLY CONTRACT AND COMPLETES PURCHASE OF FACILITY IN SPAIN Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

BRIEF-Recipharm equips a further three facilities for U.S serialisation

* RECIPHARM EQUIPS A FURTHER THREE FACILITIES FOR US SERIALISATION Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Recipharm Q3 EBITDA down at SEK ‍103​ mln

* Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO

BRIEF-Recipharm to end operations in two facilities in Sweden

* ‍TO START A PROCESS WITH INTENTION OF DISCONTINUING ACTIVITIES BOTH IN STOCKHOLM AND HÖGANÄS.​

BRIEF-Recipharm Q3 EBITDA down at SEK ‍103​ mln

* Q3 NET SALES SEK ‍1.20 BILLION VERSUS SEK 1.14 BILLION YEAR AGO

BRIEF-Recipharm starts cooperation with Roche

* RECIPHARM SIGNS LONG-TERM MANUFACTURING AGREEMENT WITH MAJOR NEW CUSTOMER AND ACQUIRES FACILITY IN SPAIN

BRIEF-Recipharm, Kancera cooperate to manufacture clinical trial supply

* RECIPHARM AND KANCERA COLLABORATE TO MANUFACTURE CLINICAL TRIAL SUPPLY

BRIEF-Recipharm Q2 EBITDA SEK 242 million

* Q2 NET SALES SEK ‍1.40 BILLION VERSUS SEK 1.24 BILLION YEAR AGO​

Select another date: